MSMarja‐Kaisa Sirén

Marja‐Kaisa Sirén

*This is an algorithmically generated author record based on publicly available information.

Marja‐Kaisa Sirén has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • H Julkunen

    Department of Internal Medicine, Peijas Hospital, Vantaa, Finland

    3 shared publications
  • R Kaaja

    Department of Obstetrics and Gynaecology, Helsinki University Hospital, Helsinki, Finland

    3 shared publications
  • H Ekblad

    Department of Paediatric Cardiology, Turku University Hospital, Turku, Finland

    1 shared publication
  • Heikki Julkunen

    Peijas Hospital, Vantaa, Helsinki University Hospital, Helsinki, Finland

    1 shared publication
  • P Kurki

    National Agency for Medicines, Helsinki, Finland

    1 shared publication
  • Risto Kaaja

    Department of Obstetrics and Gynaecology, Helsinki University Hospital, Helsinki, Finland

    1 shared publication

Latest Publications

  • Role of HLA in congenital heart block: susceptibility alleles in children

    by M-K Sire, H Julkunen, R Kaaja, H Ekblad

    Congenital heart block (CHB) is a syndrome of uncertain pathogenesis leading to cardiac conduction disturbances in the foetus and newborns. It has been proposed that maternal antibodies transmit immunological injury in the developing foetal heart, thus causing irreversible damage of the atrioventricular node, leading to third-degree atrioventricular block. However, some genetic or environmental factors may also be involved. We have searched for genetic markers that play a role in immune response and that would be pathognomonic for the disease, either in mothers by regulating their immune response or in children by affecting antigen presentation and target for the maternal immune response. We have compared HLA class I and II alleles of the children with their mother and with healthy individuals and searched for HLA markers that would be emphasized in children. We have shown that particular DQ alleles in the child predispose to CHB, perhaps serving as antigen-presenting molecules on site. In addition, the HLA-Cw3 allele is involved, although its function remains to be clarified. In our results, children with CHB were often identical to their mothers in alleles of DRB, DQA and DQB loci, thus affecting foetomaternal recognition and suggesting that cell-mediated mechanisms could be involved in the pathogenesis.


  • Role of HLA in congenital heart block: susceptibility alleles in mothers

    by M-K Sire, H Julkunen, R Kaaja, P Kurki, S Koskimies

    In congenital heart block (CHB), abnormal maternal immunisation leads to autoantibody production against SS-A/Ro and SS-B/La antigens. These maternal antibodies are transferred across the placenta to the unborn child and are believed to transmit irreversible immunological injury in developing foetal heart tissue, thus causing 3rd-degree atrioventricular block. The mothers may suffer from systemic lupus erythematosus (SLE) or primary Sjögren's syndrome (SS), but they may be asymptomatic. Women with primary SS show a typical autoimmune HLA antigen pattern, namely higher frequency of HLA B8 and DR3 than in the normal population. The HLA pattern may affect individual ability to resist infecting bacteria and viruses and to response in various ways to autoantigens. It is probable that other factors such as genetic regulation of immune response are involved in CHB. We compared the HLA class I and class II alleles of mothers having CHB children with those of women suffering from primary SS and having healthy children, and with those of healthy Finns. Antibodies against 52-kD and 60-kD SS-A/Ro and 48-kD SS-B/La antigens were compared between the two groups of mothers. Our results show that anti-SS-A/Ro antibodypositive mothers all show a strong association with known autoimmune-predisposing HLA alleles, however, the mothers of CHB children differ in some HLA class I alleles, and especially in HLA haplotypes, from mothers of healthy children. Mothers with HLA A1, Cw7, B8 and without B15 are at particularly high risk of having CHB children.


    • 1 September 1998
      • Vol. 25  (9) , 1862-4

    The increasing incidence of isolated congenital heart block in Finland.

    by M K Sirén, H Julkunen, R Kaaja


  • Congenital heart block: HLA differences between affected children and healthy siblings in four Finnish families

    by Marja‐Kaisa Sirén, Heikki Julkunen, Risto Kaaja, Saija Koskimies

    Congenital heart block without intracardiac anatomic malformations is a potentially lethal disease affecting children and newborns. The mother often has an autoimmune disorder with autoantibodies against SS-A/Ro and/or SS-B/La antigens. However, only a minority of the children of these mothers develop complete heart block. It is believed that the maternal antibodies are pathogenic, but other immunological mechanisms such as cell-mediated injury cannot be excluded. Maternal cells may recognize fetal antigens adjacent to fetal HLA, and thus some children may be more susceptible to heart block than others, depending on their HLA genetics. The purpose of this study was to evaluate whether there are HLA differences between children with heart block and their healthy siblings. Six affected children in four families and their siblings were studied. MHC class I were typed serologically and class II and some non-HLA alleles were typed by DNA techniques. DQB1*03/04 were seen more often in the affected children than in the siblings. Some other differences were also seen in the other antigens of the MHC area.